BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees7,807
Employees7,807
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees7,807
Employees7,807
BNTX Key Statistics
Market cap24.27B
Market cap24.27B
Price-Earnings ratio-12.34
Price-Earnings ratio-12.34
Dividend yield—
Dividend yield—
Average volume870.70K
Average volume870.70K
High today$98.00
High today$98.00
Low today$96.22
Low today$96.22
Open price$97.35
Open price$97.35
Volume426.68K
Volume426.68K
52 Week high$124.00
52 Week high$124.00
52 Week low$79.52
52 Week low$79.52
BNTX News
TipRanks 2d
BioNTech Steps Deeper Into Lung Cancer With New Dareon-Rosetta35 TrialBiontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. The Dareon-Rosetta35 study tests new cancer drugs in people with advanced...
Analyst ratings
67%
of 21 ratingsBuy
66.7%
Hold
28.6%
Sell
4.8%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.